{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:45:09Z","timestamp":1648849509331},"reference-count":2,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Clinica Belgica"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1080\/22953337.1996.11718535","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T08:54:41Z","timestamp":1463388881000},"page":"377-385","source":"Crossref","is-referenced-by-count":3,"title":["<i>In Vitro<\/i>Susceptibilities Of 176 Clinical Isolates Of<i>Streptococcus Pneumoniae to<\/i>11 Beta-Lactams, Erythromycin, and Tetracycline"],"prefix":"10.1080","volume":"51","author":[{"given":"R.","family":"Vanhoof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Carpcntier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Glupczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Gordts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Magerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-J.","family":"Nyssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Surmont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Van De Vyvere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Van Landuyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Van Nimmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Van Noyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2016,5,16]]},"reference":[{"key":"CIT0005","unstructured":"Marton A. Pneumococcal antimicrobial resistance: die problem in Hungary. C\/\/wInfect Dis.1992* 15106\u201311."},{"key":"CIT0017","unstructured":"Frdmaux A, Sissia G, Rosenbaum M, Gdslin P.In vitroactivity of cefpirome (HR 810) a new parenteral cephalosporin, against penicillin susceptible and resistant pneumococci.In: Program and Abstracts of the Thirty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim CA 1992. Abstract 1020 p. 280. ASM, Washington D.C."}],"container-title":["Acta Clinica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/22953337.1996.11718535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,10]],"date-time":"2016-12-10T17:30:32Z","timestamp":1481391032000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/22953337.1996.11718535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":2,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,5,16]]},"published-print":{"date-parts":[[1996,1]]}},"alternative-id":["10.1080\/22953337.1996.11718535"],"URL":"https:\/\/doi.org\/10.1080\/22953337.1996.11718535","relation":{},"ISSN":["1784-3286","2295-3337"],"issn-type":[{"value":"1784-3286","type":"print"},{"value":"2295-3337","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}